# Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
Canonical URL: https://biopharmsignal.com/news/TWST/twist-bioscience-to-present-at-william-blair-46th-annual-growth-stock-conference
Ticker: TWST
Company: Twist Bioscience Corporation
Source: Twist Bioscience Corporation
Published: 2026-06-25 13:46 EST
Original Source URL: https://investors.twistbioscience.com
## Summary

SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 27, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist Bioscience will present at the

## Article Body
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 27, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist Bioscience will present at the
## Recent Company News
- 2026-06-25 13:46 EST — [Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference](https://biopharmsignal.com/news/TWST/twist-bioscience-to-present-at-william-blair-46th-annual-growth-stock-conference) — Source: Twist Bioscience Corporation
- 2026-06-25 13:46 EST — [Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue](https://biopharmsignal.com/news/TWST/twist-bioscience-announces-preliminary-first-quarter-fiscal-2026-revenue) — Source: Twist Bioscience Corporation
- 2026-06-25 13:46 EST — [Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results](https://biopharmsignal.com/news/TWST/twist-bioscience-announces-fiscal-2026-first-quarter-financial-results) — Source: Twist Bioscience Corporation
- 2026-06-25 13:46 EST — [Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes](https://biopharmsignal.com/news/TWST/twist-bioscience-launches-next-generation-library-preparation-kits-powered-by-proprietary-enzymes) — Source: Twist Bioscience Corporation
- 2026-06-25 13:46 EST — [Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement](https://biopharmsignal.com/news/TWST/twist-bioscience-expands-antibody-discovery-offering-with-bispecific-licensing-agreement) — Source: Twist Bioscience Corporation
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)